logo

Cardiovascular Diseases

  • Home
  •  
  • Cardiovascular Diseases

Genetic Testing for Cardiovascular
Conditions is an essential strategy
to better understand an individual’s risk
to develop potentially debilitating heart
and cardiovascular conditions.

Learning in advance if a patient is genetically predisposed to specific cardiovascular conditions and abnormalities is an important step to improve clinical management and inform a wide-range of lifestyle recommendations and interventions.

Breakthrough Genomics’ Offers 10 targeted Cardiovascular Focus Panels including:

  • Aorta Panel (covers 51 genes)
  • Arrhythmia Panel (covers 57 genes)
  • Atrial Fibrillation panel (covers 19 genes)
  • Brugada Syndrome Panel (covers 9 genes)
  • Cardiomyopathy Panel (covers 24 genes)
  • Congenital Structural Heart Diseases Panel (covers 62 genes)
  • Dilated Cardiomyopathy (DCM) Panel (covers 69 genes)
  • Short QT Syndrome (SQTS) Panel (covers 111 genes)
  • CPTV Panel (covers 9 genes)
  • ARVC Panel (covers 17 genes)
Cardiovascular Genetic Risk Test Brochure

Breakthrough Genomics’ Comprehensive
Cardiovascular Test features accurate
analysis of nearly 200 genes that can impact cardiovascular health.

This test is recommended for individuals with a family-history of heart conditions of who are concerned about their long-term risk to develop heart diseases.

Benefits to genetic testing for cardiovascular conditions include:

  • informed recommendations for prevention and monitoring
  • improved clinical management decisions and treatment options
  • enhanced understanding of potential risk to family members
  • cost-savings by eliminating the need for unnecessary screening
    procedures and checkups
Test Requisition Form
Genetic Risk Variants
  • About us
  • Early Cancer Detection
  • Genetics Tests
  • Lab Services
  • Info for Partners
  • Technology
  • About BTG
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
© 2024 Breakthrough Genomics. All rights reserved.